Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Safinamide. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds. Safinamide, a monoamine oxidase B (MAO-B) inhibitor, is utilized as an adjunct to levodopa/carbidopa therapy for Parkinsons disease. By selectively inhibiting MAO-B, the enzyme responsible for dopamine breakdown in the brain, safinamide increases dopamine levels, improving motor function and alleviating symptoms of Parkinsons. Additionally, its unique non-dopaminergic effects, such as sodium channel blockade, contribute to its antiparkinsonian properties. Generally well-tolerated, safinamide represents a valuable treatment option, though careful monitoring for potential interactions is essential for optimal therapeutic outcomes in individuals with Parkinsons disease.
Buy high quality N-Nitroso Safinamide from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of N-Nitroso Safinamide.